Although it's drawing a conclusion from a sample of 3 more than one, basically 3 weeks of the spray cleared up problem pathogenic wounds without anti-biotic use. If I was a potential candidate in the stage 2 trial, I'd want to see a trajectory of scores from wounds treated with std IV anti-biotics, and the 4 result R327 graph looking noticeably better. You'd have to guess that Fiona Stanley Hospital Burns Unit have that data to assure them stage 2 trial is worth their own money. Imagine virtually any infected wound being treatable via topical gel vs less likely and invasive IV antibiotics which ain't always getting more effective, if anything, it's going backwards for many pathogens.
RCE Price at posting:
72.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)